List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 371 studies with search of:   Open Studies | "Myelodysplastic Syndromes"
  Display Options
Rank Status Study
1 Recruiting Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes
Conditions: Leukemia;   Myelodysplastic Syndromes
Interventions: Drug: arsenic trioxide;   Drug: azacitidine
2 Recruiting Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic Syndromes
Conditions: Leukemia;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
Interventions: Drug: cyclosporine;   Drug: methotrexate;   Drug: methoxsalen;   Drug: mycophenolate mofetil;   Drug: pentostatin;   Procedure: allogeneic bone marrow transplantation;   Procedure: peripheral blood stem cell transplantation;   Procedure: radiation therapy
3 Recruiting Decitabine and Tretinoin in Treating Patients With Myelodysplastic Syndromes
Condition: Myelodysplastic Syndromes
Interventions: Drug: decitabine;   Drug: tretinoin;   Procedure: DNA methylation analysis;   Procedure: cytogenetic analysis;   Procedure: flow cytometry;   Procedure: gene expression profiling;   Procedure: immunohistochemistry staining method;   Procedure: polymerase chain reaction
4 Recruiting Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes
Conditions: Leukemia;   Myelodysplastic Syndromes
Interventions: Drug: asparaginase;   Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: etoposide;   Drug: thioguanine
5 Recruiting Vaccine Therapy in Treating Patients With Myelodysplastic Syndromes
Condition: Myelodysplastic Syndromes
Interventions: Drug: GM-K562 cell vaccine;   Procedure: cytogenetic analysis;   Procedure: flow cytometry;   Procedure: fluorescence in situ hybridization;   Procedure: immunoenzyme technique;   Procedure: laboratory biomarker analysis
6 Not yet recruiting Everolimus in Treating Patients With Myelodysplastic Syndromes
Condition: Myelodysplastic Syndromes
Interventions: Drug: everolimus;   Procedure: flow cytometry;   Procedure: laboratory biomarker analysis;   Procedure: polymerase chain reaction
7 Recruiting PXD101 in Treating Patients With Myelodysplastic Syndromes
Condition: Myelodysplastic Syndromes
Intervention: Drug: belinostat
8 Recruiting Sorafenib in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndromes, or Blastic Phase Chronic Myelogenous Leukemia
Conditions: Leukemia;   Myelodysplastic Syndromes
Intervention: Drug: sorafenib tosylate
9 Recruiting Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes
Conditions: Leukemia;   Myelodysplastic Syndromes
Interventions: Drug: alemtuzumab;   Drug: arsenic trioxide;   Drug: azacitidine;   Drug: busulfan;   Drug: clofarabine;   Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: fludarabine phosphate;   Drug: gemtuzumab ozogamicin;   Drug: melphalan;   Drug: tipifarnib;   Procedure: DNA methylation analysis;   Procedure: allogeneic hematopoietic stem cell transplantation;   Procedure: cytogenetic analysis;   Procedure: gene expression analysis;   Procedure: immunologic technique;   Procedure: laboratory biomarker analysis;   Procedure: mutation analysis;   Procedure: nonmyeloablative allogeneic hematopoietic stem cell transplantation
10 Recruiting Arsenic Trioxide and Gemtuzumab Ozogamicin in Treating Patients With Advanced Myelodysplastic Syndromes
Conditions: Leukemia;   Myelodysplastic Syndromes
Interventions: Drug: arsenic trioxide;   Drug: gemtuzumab ozogamicin
11 Recruiting Lenalidomide and Azacitidine in Treating Patients With Advanced Myelodysplastic Syndromes
Conditions: Leukemia;   Myelodysplastic Syndromes
Interventions: Drug: azacitidine;   Drug: lenalidomide
12 Recruiting Iodine I 131 Monoclonal Antibody BC8, Fludarabine, Total-Body Irradiation, and Donor Stem Cell Transplant Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndromes
Conditions: Leukemia;   Myelodysplastic Syndromes
Interventions: Drug: cyclosporine;   Drug: fludarabine phosphate;   Drug: iodine I 131 monoclonal antibody BC8;   Drug: mycophenolate mofetil;   Procedure: peripheral blood stem cell transplantation;   Procedure: radiation therapy
13 Recruiting 17-N-Allylamino-17-Demethoxygeldanamycin and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Chronic Myelomonocytic Leukemia, or Myelodysplastic Syndromes
Conditions: Leukemia;   Myelodysplastic Syndromes
Interventions: Drug: cytarabine;   Drug: tanespimycin
14 Recruiting Phase I Study of Gimatecan in Patients With Myelodysplastic Syndromes
Conditions: Myelodysplastic Syndromes;   MDS
Intervention: Drug: Gimatecan
15 Recruiting A Dose Confirmation Study of Oral Clofarabine for Previously Treated Adult Patients With Intermediate-2 or High Risk Myelodysplastic Syndromes (MDS)
Condition: Myelodysplastic Syndromes
Interventions: Drug: clofarabine;   Drug: clofarabine
16 Recruiting Alemtuzumab and Cyclosporine in Treating Patients With Myelodysplastic Syndromes
Condition: Myelodysplastic Syndromes
Interventions: Drug: alemtuzumab;   Drug: cyclosporine
17 Recruiting DT388IL3 Fusion Protein in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes
Conditions: Leukemia;   Myelodysplastic Syndromes
Interventions: Drug: DT(388)IL3 fusion protein;   Procedure: flow cytometry;   Procedure: gene expression analysis;   Procedure: immunoenzyme technique;   Procedure: laboratory biomarker analysis;   Procedure: protein expression analysis
18 Not yet recruiting Lenalidomide and Decitabine in High Grade Myelodysplastic Syndromes
Condition: Myelodysplastic Syndromes
Intervention: Drug: Lenalidomide, Decitabine
19 Recruiting Vorinostat and Azacitidine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia
Conditions: Leukemia;   Myelodysplastic Syndromes
Interventions: Drug: azacitidine;   Drug: vorinostat
20 Recruiting Study of Association of Arsenic Trioxide (ATO) and Ascorbic Acid in Myelodysplastic Syndromes
Condition: Myelodysplastic Syndromes
Intervention: Drug: ATO + Ascorbic acid

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services